News | May 18, 2025
Neuland Laboratories posts Q4 FY25 consolidated PAT at Rs. 27.80 Cr
The company has posted net profit of Rs. 260.10 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 260.10 crores for the Financial Year ended March 31, 2025
Ideal for extreme dry skin and hyperkeratotic conditions such as psoriasis and ichthyosis, Ureaderm offers the next step in evidence-based, effective skin hydration
Haloperidol Decanoate Injection indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy
CuraTeQ Biologics receives approval for biosimilar Zefylti from UK’s MHRA
The company has posted net profit of Rs. 118.01 crores for the Financial Year ended March 31, 2025
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
he inspection covering the sterile drug product filling and packaging line, quality systems and quality control laboratories concluded compliance with the principles and guidelines of Good Manufacturing Practice
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Subscribe To Our Newsletter & Stay Updated
